215 related articles for article (PubMed ID: 37955201)
1. Harnessing biomaterial architecture to drive anticancer innate immunity.
Davis MA; Cho E; Teplensky MH
J Mater Chem B; 2023 Nov; 11(46):10982-11005. PubMed ID: 37955201
[TBL] [Abstract][Full Text] [Related]
2. Biomaterials as Local Niches for Immunomodulation.
Adu-Berchie K; Mooney DJ
Acc Chem Res; 2020 Sep; 53(9):1749-1760. PubMed ID: 32786230
[TBL] [Abstract][Full Text] [Related]
3. Biomaterials for enhancing anti-cancer immunity.
Koshy ST; Mooney DJ
Curr Opin Biotechnol; 2016 Aug; 40():1-8. PubMed ID: 26896596
[TBL] [Abstract][Full Text] [Related]
4. Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy.
Lee D; Huntoon K; Wang Y; Jiang W; Kim BYS
Adv Mater; 2021 Jul; 33(27):e2007576. PubMed ID: 34050699
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the Properties of Biomaterial to Enhance the Immunomodulation of Mesenchymal Stem Cells.
Chen Y; Shu Z; Qian K; Wang J; Zhu H
Tissue Eng Part B Rev; 2019 Dec; 25(6):492-499. PubMed ID: 31436142
[TBL] [Abstract][Full Text] [Related]
6. Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity.
Uher O; Caisova V; Hansen P; Kopecky J; Chmelar J; Zhuang Z; Zenka J; Pacak K
Semin Oncol; 2019; 46(4-5):385-392. PubMed ID: 31739997
[TBL] [Abstract][Full Text] [Related]
7. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Phuengkham H; Ren L; Shin IW; Lim YT
Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
[TBL] [Abstract][Full Text] [Related]
8. Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis.
Lasola JJM; Kamdem H; McDaniel MW; Pearson RM
Front Immunol; 2020; 11():1726. PubMed ID: 32849612
[TBL] [Abstract][Full Text] [Related]
9. Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.
Samojlik MM; Stabler CL
Acta Biomater; 2021 Oct; 133():87-101. PubMed ID: 34102338
[TBL] [Abstract][Full Text] [Related]
10. Boosting Checkpoint Immunotherapy with Biomaterials.
Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L
ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639
[TBL] [Abstract][Full Text] [Related]
11. Engineering vaccines and niches for immune modulation.
Purwada A; Roy K; Singh A
Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
[TBL] [Abstract][Full Text] [Related]
12. Harnessing Pyroptosis for Cancer Immunotherapy.
Bourne CM; Taabazuing CY
Cells; 2024 Feb; 13(4):. PubMed ID: 38391959
[TBL] [Abstract][Full Text] [Related]
13. Advances in tumor immunomodulation based on nanodrug delivery systems.
Wang B; Zhang Y; Yin X
Front Immunol; 2023; 14():1297493. PubMed ID: 38106403
[TBL] [Abstract][Full Text] [Related]
14. Advances in immunotherapy delivery from implantable and injectable biomaterials.
Leach DG; Young S; Hartgerink JD
Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
[TBL] [Abstract][Full Text] [Related]
15. Harnessing Biomaterials to Study and Direct Antigen-Specific Immunotherapy.
Edwards C; Carey ST; Jewell CM
ACS Appl Bio Mater; 2023 Jun; 6(6):2017-2028. PubMed ID: 37068126
[TBL] [Abstract][Full Text] [Related]
16. The role of dendritic cells in the immunomodulation to implanted biomaterials.
Wang S; Chen Y; Ling Z; Li J; Hu J; He F; Chen Q
Int J Oral Sci; 2022 Nov; 14(1):52. PubMed ID: 36333287
[TBL] [Abstract][Full Text] [Related]
17. Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.
Ye Z; Shi Y; Lees-Miller SP; Tainer JA
Front Immunol; 2021; 12():797880. PubMed ID: 34970273
[TBL] [Abstract][Full Text] [Related]
18. The inflammasome in biomaterial-driven immunomodulation.
Vasconcelos DP; Águas AP; Barbosa JN
J Tissue Eng Regen Med; 2022 Dec; 16(12):1109-1120. PubMed ID: 36327091
[TBL] [Abstract][Full Text] [Related]
19. Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor Immunity.
Levy ES; Chang R; Zamecnik CR; Dhariwala MO; Fong L; Desai TA
Mol Pharm; 2021 Mar; 18(3):1014-1025. PubMed ID: 33541072
[TBL] [Abstract][Full Text] [Related]
20. Control of innate immune response by biomaterial surface topography, energy, and stiffness.
Abaricia JO; Farzad N; Heath TJ; Simmons J; Morandini L; Olivares-Navarrete R
Acta Biomater; 2021 Oct; 133():58-73. PubMed ID: 33882355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
